Company / Operating Cash Flow per Share
Biohaven Ltd. Operating Cash Flow per Share History
FY2020-FY2024 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Operating Cash Flow per Share
-$6.38
FY2024
5-year range
-$6.65 / -$1.93
FY2020-FY2024
Trend
-37.0%
vs FY2023
Sector context
#204 of 212
Health Care
What the data says
Among 212 Health Care companies, Biohaven Ltd. is in the bottom 4% for operating cash flow per share. Improved from $-6.65 to $-6.38 over the past 2 years.
Based on SEC 10-K filings.
-6.38 in FY2024.
Improved from $-6.65 to $-6.38 over the past 2 years.
Health Care sector context is included.
Operating Cash Flow per Share over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Sector benchmark
Bottom 4% in Health CareTop 96% of 212This company -$6.38 Sector average $5.28
▼
-221.0% below sector average
Key checks
Key Insights
- In FY2024, operating cash flow per share decreased 37.0% year-over-year.
- Ranks #204 out of 212 companies in the Health Care sector.
- Peak operating cash flow per share was recorded in FY2020.
- Lowest operating cash flow per share in the period was in FY2022.
Company context
Key Data Points
- Low Piotroski F-Score: 1/9 (multiple financial health concerns)
- Altman Z-Score -3.10 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Operating Cash Flow per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2024 | -$6.38 | -37.0% |
| FY2023 | -$4.66 | +30.0% |
| FY2022 | -$6.65 | -79.6% |
| FY2021 | -$3.70 | -92.0% |
| FY2020 | -$1.93 | - |
As of FY2024 · SEC 10-K · Updated Feb 28, 2026